首页> 美国卫生研究院文献>other >Multifunctional Thiosemicarbazones and Deconstructed Analogues as a Strategy to Study the Involvement of Metal Chelation Sigma-2 (σ2) Receptor and P-gp Protein in the Cytotoxic Action: in vitro and in vivo Activity in Pancreatic Tumors
【2h】

Multifunctional Thiosemicarbazones and Deconstructed Analogues as a Strategy to Study the Involvement of Metal Chelation Sigma-2 (σ2) Receptor and P-gp Protein in the Cytotoxic Action: in vitro and in vivo Activity in Pancreatic Tumors

机译:多功能硫代氨基脲和解构类似物作为研究金属螯合Sigma-2(σ2)受体和P-gp蛋白参与细胞毒性作用的策略:胰腺肿瘤的体外和体内活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aggressiveness of pancreatic cancer urgently requires more efficient treatment options. Because the sigma-2 (σ2) receptor was recently proposed as a promising target for pancreatic cancer therapy, we explored our previously developed multifunctional thiosemicarbazones, designed to synergistically impair cell energy levels, by targeting σ2 and P-gp proteins and chelating Iron. A deconstruction approach was herein applied by removing one function at a time from the potent multifunctional thiosemicarbazones >1 and >2, to investigate the contribution to cytotoxicity of each target involved. The results from in vitro (panel of pancreatic tumor cells) and in vivo experiments (C57BL/6 bearing KP02 tumor), suggest that while the multifunctional activity was not required for the antitumor activity of these thiosemicarbazones, σ2-targeting appeared to allow alternative tumor cell death mechanisms, leading to potent and less toxic off-targets toxicities compared to other thiosemicarbazones devoid of σ2-targeting.
机译:胰腺癌的侵袭性迫切需要更有效的治疗选择。由于sigma-2(σ2)受体是最近被提出作为胰腺癌治疗的有希望的靶标,因此我们探索了我们先前开发的多功能硫代半乳糖苷,旨在通过靶向σ2和P-gp蛋白并螯合铁来协同削弱细胞能量水平。本文采用一种解构方法,通过一次从强大的多功能硫代半脲化合物> 1 和> 2 中去除一个功能来研究每个靶标对细胞毒性的影响。体外(胰腺肿瘤细胞面板)和体内实验(带有KP02肿瘤的C57BL / 6)的结果表明,尽管这些硫代半氨基甲酰胺的抗肿瘤活性不需要多功能活性,但靶向σ2的靶标似乎可以替代肿瘤细胞死亡机制,与其他没有σ2靶向作用的硫代半脲类药物相比,具有更强的毒性和更低的脱靶毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号